Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,428,643
-$12,130,733 QoQ
Shares Held
504,171
-27.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#61
of 1,033 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. GSK ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
This page
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in GSK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,428,643 | 504,171 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,559,376 | 698,666 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $69,466,386 | 1,416,525 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $60,499,745 | 1,401,755 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $51,611,212 | 1,344,042 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $46,607,900 | 1,203,095 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $76,016,909 | 2,247,691 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $39,483,375 | 965,836 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,934,301 | 465,826 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,800,053 | 135,294 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,931,581 | 214,020 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,453,877 | 178,038 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,812,122 | 191,137 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,502,518 | 154,652 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,672,846 | 132,978 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,579,863 | 87,661 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,913,395 | 91,661 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,195,504 | 98,201 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,015,504 | 92,837 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,483,672 | 119,640 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,426,467 | 113,338 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||